MedWatch

Expres2ion hopes for milestones after promising malaria data

The first vaccine against placental malaria might be one step closer to reality. If the development is successful, Danish Expres2ion will receive milestones and royalties for its central role in the development.

Foto: Colourbox

Causing 222,000 deaths every year, placental malaria pose a global health problem. But now, a prophylactic vaccine against the disease has come one step closer to realization.

A research team from University of Copenhagen recently presented positive data from a phase I trial with the vaccine in healthy volunteers.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier